Acceptance-Based Treatment for Generalized Anxiety Disorder

Sponsor
University of Massachusetts, Boston (Other)
Overall Status
Completed
CT.gov ID
NCT00073632
Collaborator
National Institute of Mental Health (NIMH) (NIH)
50
1
51
1

Study Details

Study Description

Brief Summary

This study will develop and implement an awareness- and acceptance-based for treatment of individuals with generalized anxiety disorder.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Acceptance Based Behavioral Therapy
Phase 1

Detailed Description

Participants in this study are recruited from intakes at the Center for Anxiety and Related Disorders at Boston University. Participants will be randomly assigned to receive either acceptance and mindfulness-based strategies plus cognitive behavioral therapy or no treatment for 16 weeks. The treatment will involve daily practice of mindfulness techniques to help draw attention to and accept various emotional states. Interviews, questionnaires, and depression and anxiety scales will be used to assess participants. Assessments will be conducted post-treatment and at 3- and 9-month follow-up visits.

Study Design

Study Type:
Interventional
Actual Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Developing a New Therapy for GAD: Acceptance-Based CBT
Study Start Date :
May 1, 2002
Actual Primary Completion Date :
Jul 1, 2006
Actual Study Completion Date :
Aug 1, 2006

Outcome Measures

Primary Outcome Measures

  1. Clinician Severity Rating from ADIS for GAD [pre, post, 3 mo. f/u, 9 mo. f/u]

  2. Penn State Worry Questionnaire [pre-, post-, 3 mo. f/u, 9 mo. f/u]

  3. Depression Anxiety and Stress Scales, anxiety and stress subscales [pre-, post-, 3 mo. f/u, 9 mo. f/u]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Generalized Anxiety Disorder (GAD)

  • Willing to maintain medication levels and refrain from any additional psychosocial treatment during the course of the study

Exclusion Criteria:
  • Bipolar disorder, psychotic disorder, or substance dependence

Contacts and Locations

Locations

Site City State Country Postal Code
1 Center for Anxiety and Related Disorders Boston Massachusetts United States

Sponsors and Collaborators

  • University of Massachusetts, Boston
  • National Institute of Mental Health (NIMH)

Investigators

  • Principal Investigator: Lizabeth Roemer, PhD, University of Massachusetts, Boston
  • Principal Investigator: Susan M Orsillo, PhD, Boston University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00073632
Other Study ID Numbers:
  • R21MH063208
  • R21MH063208
  • DSIR AT-AS
First Posted:
Dec 3, 2003
Last Update Posted:
Nov 6, 2013
Last Verified:
Sep 1, 2008
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 6, 2013